Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$177000.0.

  • Immunocore Holdings' Profit After Tax fell 10202.61% to -$177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 3787.99%. This contributed to the annual value of -$51.1 million for FY2024, which is 759.67% up from last year.
  • Latest data reveals that Immunocore Holdings reported Profit After Tax of -$177000.0 as of Q3 2025, which was down 10202.61% from -$10.3 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Profit After Tax peaked at $8.7 million during Q3 2024, and registered a low of -$53.2 million during Q4 2021.
  • Over the past 5 years, Immunocore Holdings' median Profit After Tax value was -$18.2 million (recorded in 2023), while the average stood at -$18.0 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 12859.06% in 2023, then skyrocketed by 86423.84% in 2024.
  • Immunocore Holdings' Profit After Tax (Quarter) stood at -$53.2 million in 2021, then surged by 34.73% to -$34.7 million in 2022, then soared by 43.15% to -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then skyrocketed by 99.26% to -$177000.0 in 2025.
  • Its Profit After Tax stands at -$177000.0 for Q3 2025, versus -$10.3 million for Q2 2025 and $5.0 million for Q1 2025.